Gonadal toxicity of Hodgkin lymphoma treatment in adolescents and young males: issue relevance and ways of solve (literature review)
- Authors: Vinokurov A.A.1, Varfolomeeva S.R.1, Tarusin D.I.2
-
Affiliations:
- Federal Research Center of Pediatric Hematology, Oncology and Immunology
- Scientific and Practical Center of Children and Adolescents Andrology Moscow Department of Public Health
- Issue: Vol 6, No 2 (2011)
- Pages: 12-18
- Section: HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE
- Published: 23.05.2011
- URL: https://oncohematology.abvpress.ru/ongm/article/view/97
- DOI: https://doi.org/10.17650/1818-8346-2011-6-2-12-18
- ID: 97
Cite item
Full Text
Abstract
Hodgkin`s Lymphoma (HL) is one of the most curable cancer disease. A half of all patients are young males under 35 years old. Gonadal toxicity is one of the most frequent late effects of HL therapy and associated with significant decrease in patient’s quality of life. In present article frequency and risk factors of gonadal toxicity in males with HL were summarized. It was shown that chemotherapy with alkylating agents and radiotherapy may lead to gonadal toxicity in significant number of patients. Current possibilities of semen cryopreservation before start of the treatment are discussed.
About the authors
A. A. Vinokurov
Federal Research Center of Pediatric Hematology, Oncology and Immunology
Author for correspondence.
Email: a_vinokurov@inbox.ru
Russian Federation
S. R. Varfolomeeva
Federal Research Center of Pediatric Hematology, Oncology and ImmunologyRussian Federation
D. I. Tarusin
Scientific and Practical Center of Children and Adolescents Andrology Moscow Department of Public HealthRussian Federation
References
Supplementary files

